Cato Laurencin

Cato Laurencin

Director/Board Member presso ALKERMES PLC

Patrimonio netto: 1 M $ in data 31/03/2024

65 anni
Consumer Services
Commercial Services
Health Technology

Profilo

Cato T.
Laurencin
is the founder of Biorez, Inc. (founded in 2008) and Natural Polymer Devices, Inc. (founded in 2011), where he holds the title of President, CEO, Secretary & Director.
Dr. Laurencin is also the founder of W Montague Cobb.
Dr. Laurencin's current job(s) include being the Chief Executive Officer of the Connecticut Institute For Clinical & Translational Science, the Chief Executive Officer of The Cato T Laurencin Institute For Regenerative Engineering, the Director of the American Institute of Chemical Engineers (since 2018), an Independent Director of MiMedx Group, Inc., an Independent Director of Alkermes Plc (since 2021), a Member of the National Academy of Sciences, a Member of the American Academy of Arts & Sciences, a Member of the National Academy of Engineering, the Chief Editor of Springer Nature Switzerland AG, and a Member of the National Academy of Medicine (United States).
He is also a Professor at the University of Connecticut (since 2008).
Dr. Laurencin's former job(s) include being the Chairman-Orthopedic Surgery & Professor at the University of Virginia, a Director at Osteotech, Inc. (from 2008 to 2010), a Director at Connecticut Children's Medical Center, the Chief Resident-Orthopedic Surgery at Beth Israel Hospital, a Professor at Drexel University College of Medicine, the Dean of The University of Connecticut School of Medicine (from 2003 to 2008), and the Vice President-Health Affairs at the University of Connecticut Health Center.
Dr. Laurencin's education history includes a doctorate degree from the Massachusetts Institute of Technology, an undergraduate degree from Princeton University, and a doctorate degree from Harvard Medical School.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
13/06/2023 130 124 ( 0.09% ) 1 M $ 31/03/2024
15/02/2024 15 169 ( 0.01% ) 410 625 $ 31/03/2024

Posizioni attive di Cato Laurencin

SocietàPosizioneInizio
MIMEDX GROUP, INC. Director/Board Member -
ALKERMES PLC Director/Board Member 18/11/2021
Founder 17/06/2011
Springer Nature Switzerland AG Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
University of Connecticut Corporate Officer/Principal 01/01/2008
Director/Board Member 29/10/2018
Connecticut Institute For Clinical & Translational Science Chief Executive Officer -
Tutte le posizioni attive di Cato Laurencin

Precedenti posizioni note di Cato Laurencin

SocietàPosizioneFine
░ ░░░░░░░░ ░░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░ ░░░░ ░░░░░░░ -
Vedi nel dettaglio l'esperienza di Cato Laurencin

Formazione di Cato Laurencin

Massachusetts Institute of Technology Doctorate Degree
Princeton University Undergraduate Degree
Harvard Medical School Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Cato Laurencin

Relazioni

100 +

Relazioni di 1° grado

23

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
MIMEDX GROUP, INC.

Health Technology

ALKERMES PLC

Health Technology

Aziende private13

Health Technology

Health Technology

Electronic Technology

Health Services

Health Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Connecticut Institute For Clinical & Translational Science

Springer Nature Switzerland AG

W Montague Cobb/Nma Health Institute

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Cato Laurencin